Exact Sciences Corporation
The Senior Cybersecurity Risk Remediation Analyst serves as the central coordination point for enterprise cybersecurity remediation efforts, driving the resolution of risks identified through assessments, vulnerability management, and compliance activities. This role requires translating security findings into actionable plans, tracking milestones, and engaging stakeholders to ensure timely closure of remediation efforts while supporting risk management education. The position demands a deep understanding of security risk principles and the ability to integrate security into business operations within a collaborative team environment.
Headquarters
Madison, Wisconsin, United States
Company Size
5001-10000 employees
Founded
1995
Exact Sciences is a leading company dedicated to cancer prevention and early detection through innovative testing solutions. Specializing in molecular diagnostics, the firm provides advanced tests that help identify potential malignancies and guide therapy decisions. Their flagship product, Cologuard, is a non-invasive screening test for colorectal cancer, contributing significantly to patient health management. Exact Sciences aims to enhance patient outcomes by promoting early detection and regular screenings.
First Trust Advisors LP Grows Stock Position in Exact Sciences Corporation $EXAS
5 hours ago
Mackenzie Financial Corp Has $150.11 Million Stake in Exact Sciences Corporation $EXAS
4 hours ago
Exact Sciences EHR Outreach Program Highlights Cologuard Growth And Valuation Debate
5 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exact Sciences Corporation.
8% above the average for this role
Exact Sciences Stockholders Approve Acquisition by Abbott
3 weeks ago